AUTL - CIK 0001730463
Autolus Therapeutics plc (AUTL) reported revenue of $75.39M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $75.39M | +644.9% |
| FY 2024 | $10.12M | +496.0% |
| FY 2023 | $1.70M | -41.6% |
| FY 2019 | $2.91M | +106.7% |
| FY 2018 | $1.41M | -16.9% |
| FY 2017 | $1.69M | +39.7% |
| FY 2016 | $1.21M | - |
Autolus Therapeutics plc (AUTL) reported revenue of $75.39M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2016 and fiscal 2025, Autolus Therapeutics plc's revenue grew from $1.21M to $75.39M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.